Skip to main content
Announcement:
Kane Biotech Announces Agreement to Acquire FB Dermatology
See Video
Kane Biotech
Biofilms
Overview
Understanding Biofilms
coactiv+™
DispersinB
®
Glossary Of Terms
Commercialization Vehicles
Overview
Kane Wound Care & Surgical
Kane Dermatology
About
Overview
Our Team
Careers
Contact
Publications
Blog
Publications / Posters
News / Events
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
Sedar
Corporate Governance
Video Archives
Kane Biotech Announces Agreement to Acquire FB Dermatology
Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification
Bioscience Company of the Year (video produced by BAM)
Welcome our new Executive Chairman of the Board: Dr. Robert Huizinga
Kane Biotech Receives Company of the Year Award from BAM
Kane Biotech Files New Patent On revyve™ Antimicrobial Wound Gel Spray
Kane Biotech Receives Offer for its Interest in STEM Animal Health
Kane Biotech: Update by CEO for Oct 2023
Medtec Models & Misfires Webinar
Antimicrobial Stewardship and Biofilms: Research Opportunities
Nucleus195: Diamonds in the Rough